HK1209027A1 - 囊泡製劑、用途和方法 - Google Patents

囊泡製劑、用途和方法

Info

Publication number
HK1209027A1
HK1209027A1 HK15109429.5A HK15109429A HK1209027A1 HK 1209027 A1 HK1209027 A1 HK 1209027A1 HK 15109429 A HK15109429 A HK 15109429A HK 1209027 A1 HK1209027 A1 HK 1209027A1
Authority
HK
Hong Kong
Prior art keywords
methods
vesicular formulations
vesicular
formulations
Prior art date
Application number
HK15109429.5A
Other languages
English (en)
Inventor
Richard Wolf Garraway
John Mayo
William Henry
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Publication of HK1209027A1 publication Critical patent/HK1209027A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
HK15109429.5A 2012-05-14 2015-09-24 囊泡製劑、用途和方法 HK1209027A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208384A GB201208384D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, uses and methods
PCT/EP2013/059740 WO2013171131A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, uses and methods

Publications (1)

Publication Number Publication Date
HK1209027A1 true HK1209027A1 (zh) 2016-03-24

Family

ID=46458741

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109429.5A HK1209027A1 (zh) 2012-05-14 2015-09-24 囊泡製劑、用途和方法

Country Status (9)

Country Link
US (1) US20150125407A1 (zh)
EP (1) EP2849721A1 (zh)
JP (1) JP2015516453A (zh)
CN (1) CN104411298A (zh)
DE (1) DE112013002492T5 (zh)
GB (1) GB201208384D0 (zh)
HK (1) HK1209027A1 (zh)
IN (1) IN2014DN10134A (zh)
WO (1) WO2013171131A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011022707A1 (en) 2009-08-21 2011-02-24 Henk-Andre Kroon Vesicular formulations
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
EP3954361A1 (en) 2015-06-30 2022-02-16 Sequessome Technology Holdings Limited Multiphasic compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501289A (ja) * 1985-09-27 1988-05-19 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア リポソ−ム経皮薬剤供給系
CA2067754C (en) 1990-08-24 2002-06-04 Gregor Cevc Preparation for the application of agents in mini-droplets
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
JPH06293615A (ja) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd 混合脂質膜小胞を含有する化粧品
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20100150994A1 (en) * 2006-12-01 2010-06-17 Anterios, Inc. Amphiphilic entity nanoparticles
ES2335636B1 (es) * 2008-02-29 2011-05-11 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica de micelas mixtas.
GB2483419B (en) 2009-06-03 2015-04-08 Sequessome Technology Holdings Ltd Formulations for the treatment of deep tissue pain
WO2011022707A1 (en) 2009-08-21 2011-02-24 Henk-Andre Kroon Vesicular formulations

Also Published As

Publication number Publication date
JP2015516453A (ja) 2015-06-11
IN2014DN10134A (zh) 2015-08-21
DE112013002492T5 (de) 2015-02-19
CN104411298A (zh) 2015-03-11
US20150125407A1 (en) 2015-05-07
EP2849721A1 (en) 2015-03-25
WO2013171131A1 (en) 2013-11-21
GB201208384D0 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
HK1208165A1 (zh) 藥物偶聯物，偶聯方法，及其用途
HK1209079A1 (zh) 催化的劑型和配方
HK1199023A1 (zh) 取代的苯並噻吩基-吡咯並三嗪及其用途
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
HK1203493A1 (zh) 取代的氮雜雙環及其用途
HK1200822A1 (zh) 取代的聯吡啶胺及其用途
HK1210913A1 (zh) 粒子、方法以及其用途
PL2831055T3 (pl) Zdolne do polimeryzacji alkilideno-1,3-dioksolan-2-ony i ich zastosowanie
HK1212625A1 (zh) 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑
IL251974A0 (en) Antifibrosis compounds and their uses
HK1209636A1 (zh) 反式克羅米酚 調配物和其用途
HK1203198A1 (zh) 取代的苯基咪唑並吡唑及其用途
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
GB201223330D0 (en) Products, methods and uses
EP2903979A4 (en) Novel compounds, their preparation and use
HK1213142A1 (zh) 分離軸、軸轂組件及其用途
HK1210809A1 (zh) β己糖基轉移酶及其用法
IL234747A0 (en) Vascular formulations
HK1209027A1 (zh) 囊泡製劑、用途和方法
HK1209026A1 (zh) 囊泡製劑、試劑盒和用途
GB201208360D0 (en) Vesicular formulations,kits and uses
HK1202249A1 (zh) 囊泡製劑
EP2944172A4 (en) AXIS IN TWO PARTS, AXLE-HUB ASSEMBLY AND USE THEREOF